Skip to main content
Clinical Trials/JPRN-UMIN000026013
JPRN-UMIN000026013
Completed
未知

Efficacy of memantine in patients with moderate-to-severe Alzheimer's disease: results of pooled analysis, using realistic definitions of response, of two randomized, double-blind, placebo-controlled trials in Japan - A pooled analysis of efficacy of memantine in patients with moderate-to-severe Alzheimer's disease (MEM-DS-15019)

Daiichi Sankyo Co., LTD.0 sites633 target enrollmentFebruary 6, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Alzheimer&#39
Sponsor
Daiichi Sankyo Co., LTD.
Enrollment
633
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 6, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who did not have a result of efficacy assessment at the start of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials